NCT07122557View on ClinicalTrials.gov

Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073

Not yet recruitingOBSERVATIONAL

Enrollment

320

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

October 31, 2025

Study Completion Date

December 31, 2025

Conditions

HIV-1Public Universal Healthcare Insurance CoverageBIC/FTC/TAFLow Income Population

Interventions

DRUG

Biktarvy

this study applies secondary use of data collected from medical health records

All Listed Sponsors

lead

Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba

OTHER

NCT07122557 - Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073 | Biotech Hunter | Biotech Hunter